Market Cap | 11.08M | P/E | - | EPS this Y | 17.50% | Ern Qtrly Grth | - |
Income | -6.24M | Forward P/E | - | EPS next Y | 38.50% | 50D Avg Chg | -40.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -48.00% |
Dividend | N/A | Price/Book | 2.45 | EPS next 5Y | - | 52W High Chg | -87.00% |
Recommedations | 2.00 | Quick Ratio | 3.44 | Shares Outstanding | 1.07M | 52W Low Chg | 4.00% |
Insider Own | 46.72% | ROA | -91.90% | Shares Float | 568.58K | Beta | - |
Inst Own | 2.19% | ROE | -174.01% | Shares Shorted/Prior | 19.35K/4K | Price | 0.85 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 390,282 | Target Price | 45.00 |
Oper. Margin | - | Earnings Date | - | Volume | 53,124 | Change | -2.31% |
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
HC Wainwright & Co. | Buy | Jun 6, 24 |
HC Wainwright & Co. | Buy | May 9, 24 |
HC Wainwright & Co. | Buy | Mar 14, 24 |
Noble Capital Markets | Outperform | Dec 18, 23 |
HC Wainwright & Co. | Buy | Nov 20, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
MURPHY JOHN RAYMOND | Director Director | Oct 04 | Buy | 0.7 | 20,000 | 14,000 | 614,792 | 10/06/23 |
Pham Quang X | CEO and Chairman CEO and Chairman | Sep 05 | Buy | 0.9 | 40,000 | 36,000 | 3,410,000 | 09/06/23 |
Pham Quang X | CEO and Chairman CEO and Chairman | Sep 01 | Buy | 0.91 | 70,000 | 63,700 | 3,370,000 | 09/05/23 |
MURPHY JOHN RAYMOND | Director Director | Mar 16 | Buy | 1.6699 | 20,000 | 33,398 | 574,792 | 03/16/23 |